• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 14, 2013

  • Print
  • Share
  • E-mail

Event Detail

Event ID 65701
Product Type Drugs
Status Ongoing
Recalling Firm Sanofi US
City Bridgewater
State NJ
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-03-07
Initial Firm Notification of
Consignee or Public
Distribution Pattern Nationwide

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30 Lot # 3097657, Exp 3/15 Class II Subpotent drug: low fill volume in some of the capsules 2,462 bottles D-841-2013